Filter
573
Filtered Results: 573
Text search:
TB
co-morbidities
Featured
Recommendations
72
New Publications
143
Language
Document type
No document type
323
Guidelines
103
Studies & Reports
88
Strategic & Response Plan
25
Manuals
15
Situation Updates
5
Fact sheets
5
Training Material
4
Infographics
4
Resource Platforms
1
Countries / Regions
India
29
South Africa
23
Kenya
22
Global
22
Western and Central Europe
21
Ethiopia
14
Africa
13
Latin America and the Carribbean
13
Eastern Europe
13
Uganda
11
Rwanda
10
Tanzania
10
Ghana
9
Namibia
9
Zambia
9
South–East Asia Region
8
Nepal
7
Ukraine
7
Sierra Leone
7
Nigeria
7
Asia
7
Bangladesh
7
Malawi
6
Brazil
6
Myanmar / Burma
6
Eswatini/ Swaziland
5
Senegal
4
Congo, Democratic Republic of
4
East and Southern Africa
4
Lesotho
3
Zimbabwe
3
Cambodia
3
Russia
3
Georgia
3
Tajikistan
2
Colombia
2
Cameroon
2
Laos
2
Burkina Faso
2
Peru
2
Philippines
2
Germany
2
West and Central Africa
2
Western Pacific Region
2
Argentina
2
Vietnam
2
Botswana
2
Liberia
2
Madagascar
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Gambia
1
Chile
1
Syria
1
Estonia
1
Burundi
1
Venezuela
1
Middle East and North Africa
1
Paraguay
1
North America
1
Gabon
1
Bolivia
1
Romania
1
Central African Republic
1
South Sudan
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
232
Clinical Guidelines
72
Public Health
25
Women & Child Health
5
Capacity Building
3
Key Resources
3
Pharmacy & Technologies
1
Toolboxes
TB
157
HIV
109
COVID-19
46
NCDs
16
AMR
15
Mental Health
13
NTDs
11
Refugee
8
Conflict
6
Pharmacy
4
Health Financing Toolbox
4
Ebola & Marburg
3
Caregiver
3
Polio
3
Rapid Response
2
Disability
2
Cholera
1
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early ...
Global HIV Strategic Information Working Group
For Populations At Risk For HIV
Physical distancing measures are important to reduce COVID-19 transmission. However, when stringently applied, they can result in negative health and socio-economic impacts. This report draws on a rapid review of available literature, case studies from across Africa and expert knowledge to make reco...
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
Global AIDS Update 2017
The global burden of disease due to mental disorders continues to rise, especially in low- and middle-income countries (LMIC). In addition to causing a large proportion of morbidity, mental disorders – especially severe mental disorders (SMD) – are linked with poorer health outcomes and increase...
Q7. SCOPING QUESTION: In adults with moderate-severe depressive disorder, what is the effectiveness and safety of antidepressant medication (ADM) in comparison with psychological treatment?
The WHO mhGAP programme’s existing guidelines recommend that either structured brief psychological treatm...
An analysis from the perspective of the health sector in Latin America and the Caribbean
Washington, D.C., 2017
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The 2030 health-related Sustainable Development Goals call on countries to end AIDS as a public health threat and also to achieve universal health coverage. The World Health Organization (WHO) promotes primary health care (PHC) as the key mechanism for achieving universal health coverage, and the PH...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
UNAIDS 2018 reference
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The seventh WHO Report on the global tobacco epidemic analyses national efforts to implement the most effective measures from the WHO Framework Convention on Tobacco Control (WHO FCTC) that are proven to reduce demand for tobacco.
The report showed that while only 23 countries have implemented ce...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Research Article
Hindawi Publishing Corporation
AIDS Research and Treatment
Volume 2011, Article ID 621078, 7 pages doi:10.1155/2011/621078
UNAIDS 2019, Reference
This edition of UNAIDS data shows the results of some of those successes, but also the challenges that remain. It contains the very latest data on the world’s response to HIV, consolidating a small part of the huge volume of data collected, analysed and refined by UNAIDS ov...
